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BACKGROUND
SP-D is a collectin widely distributed on mucosal surfaces of the body
including the gastrointestinal tract (1). It is part of the innate immune system
and mediates control of pro-inflammatory mechanisms.
Genetic variations of SP-D have recently been associated to inflammatory
bowel disease (IBD) in a Japanese population and showed association to
ulcerative colitis (UC) (2). In contrast, an American case-control analysis
revealed a significant association between a specific SP-D genetic variant
and susceptibility to Crohn’s disease (CD), but not to UC (3).
Together these two studies suggest that SP-D is involved in IBD and warrant
in vivo studies of the related pathophysiological mechanisms.
AIM
We aimed to investigate the expression of SP-D in IBD patients and
compared it to the intestinal inflammatory activity, and we compared the
inflammatory response between Sftpd+/+ (WT) and Sftpd-/- (KO) mice in a
dextran sodium sulfate (DSS) model of colitis.
We hypothesized that SP-D dampens intestinal inflammation by reducing
innate inflammatory signaling and facilitate clearance of apoptotic cells.
METHODS
Surgical specimens from IBD patients (n=27) including Crohn’s disease
(CD) (n=9) and ulcerative colitis (UC) (n=18) were immunohistochemically
stained for SP-D. The tissue specimens was scored for SP-D expression
and inflammatory activity.
Colitis was induced in WT and KO littermates by supplementing the ad
libitum water with DSS.
Colon tissue were stained with hematoxylin & eosin to estimate the
histological damage, and immunohistochemical staining’s were used to
analyze levels of apoptosis, necrosis and inflammatory infiltration.
Colon tissue samples were analyzed for inflammatory markers (TNF-α, IL-6,
INF-γ and CCL-2) by ELISA analysis.
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CONCLUSION
- Limited anti-inflammatory effects of SP-D  in DSS-induced 
inflammation in mice. 
- Positive correlation between inflammatory activity and immunoscore
for SP-D observed in surgical specimens from IBD patients.
- SP-D is upregulated in clinical disease.
Day 0: 
Start of treatment 
with DSS
Day 7: 
Mice receiving 1.5% 
DSS are terminated
1% DSS is replaced 
with water
Day 10: 
Mice are terminated 
after receiving water 
for 3 days
RESULTS
- We found a significant correlation between the expression of intestinal
SP-D and inflammatory activity in IBD patients (Fig. 1).
- Mice treated with DSS did experience a notable weight loss and
increased disease activity index (DAI) score (Fig. 2), but there were no
difference between WT and KO.
- ELISA analysis showed a significant difference in the levels of TNF-α
between WT and KO in the restitution phase and qRT-PCR did show a
tendential upregulation of Sftpd in WT mice treated with DSS (Fig. 3, A-
B). There were no difference in histologic damage or colon length
between WT and KO (Fig. 3, C-D).
Fig. 3: A) ELISA analysis showed a significant difference between colonic
levels of TNF-α in WT compared to KO in the restitution phase. B) Quantative
real-time PCR of murine expression of SP-D in the colon. C) Histological
damage score. D) Length of colon. All data are presented with SEM.
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Fig. 1: A) Correlation of immunoscore and inflammatory activity in surgical
specimens from IBD patients. B) Immunostaining for SP-D in a patient with
UC. C) Immunostaining for SP-D in a patient with CD
Fig. 2: A) Weight loss. B) DAI score. All data are presented with SEM.
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